A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: incorporated (115), integrated (151)

Preventing blood clots - patient information

Description
Blood normally flows quickly and uninterrupted through our veins. Sometimes, however, clots can form that either reduce the blood flow or
Url
/Media/UHS-website-2019/Patientinformation/Visitinghospital/Preventingbloodclots-patientinformation.pdf

Erlotinib

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) ERLOTINIB Regimen NSCLC - Erlotinib Indication Second line therapy of stage IIIB or IV
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Erlotinibver12.pdf

Cisplatin and Pemetrexed

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CISPLATIN-PEMETREXED Regimen NSCLC – Cisplatin-Pemetr
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/CisplatinandPemetrexedver12.pdf

Vinorelbine (intravenous)

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) VINORELBINE (Intravenous) Regimen NSCLC - Vinorelbine (Intravenous) Indication Second line therapy of stage III
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Vinorelbineintravenousver12.pdf

Ipilimumab Ver 1

Description
Chemotherapy Protocol SKIN CANCER IPILIMUMAB Regimen Skin – Ipilimumab Indication Ipilimumab is recommended, within its marketing authorisation, as an option for treating
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/SkinIpilimumabVer1.pdf

Dabrafenib Trametinib Ver1

Description
Chemotherapy Protocol SKIN CANCER DABRAFENIB-TRAMETINIB Regimen  Skin – Dabrafenib-Trametinib Indication  The combination of dabrafenib and trametinib is recommended as an
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/SkinDabrafenibTrametinibVer1.pdf

HSCTAlemtuzumabFludarabineMelphalan-VUD-Methotrexate-GvHD

Description
Chemotherapy Protocol HAEMATOLOGY – HSCT ALLOGRAFT ALEMTUZUMAB-FLUDARABINE-MELPHALAN-METHOTREXATE (GVHD) Volunteer Unrelated Donor (VUD) Conditioning This
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Transplant/HSCTAlemtuzumabFludarabineMelphalan-VUD-Methotrexate-GvHD.pdf

HSCTAlemtuzumabBusulphan-12-Fludarabine-VUD-Methotrexate-GvHD

Description
Chemotherapy Protocol HAEMATOLOGY – HSCT ALLOGRAFT ALEMTUZUMAB-BUSULFAN (12 doses)-FLUDARABINE-METHOTREXATE (GvHD) Volunteer Unrelated Donor (VUD) CONDITI
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Transplant/HSCTAlemtuzumabBusulphan-12-Fludarabine-VUD-Methotrexate-GvHD.pdf

Psychology Service Referral- paper equest version

Description
Service Referral Adult Psychology referral PATIENT DETAILS Patient Name: Date of Birth: Address: Hospital Number: NHS Number: Sex: Phone No: GP
Url
/Media/UHS-website-2019/Docs/Services/psychology-service-referral-paper-equest-version.docx

Mental wellbeing support on the neonatal intensive care unit (NICU) - patient information

Description
Patient information factsheet Mental wellbeing support on the neonatal intensive care unit (NICU) If your baby is unwell or has been
Url
/Media/UHS-website-2019/Patientinformation/Neonatal/Mental-wellbeing-support-on-the-neonatal-intensive-care-unit-NICU-2291-PIL.pdf
491 to 500 of 1000
Previous … 48 49 50 51 52 … Next